Pubertal Exposure to Tebuconazole Increases Testosterone Production Via Inhibiting Testicular Aromatase Activity in Rats.

Xiuxiu Chen,Qiqi Zhu,Xiaoheng Li,Tongliang Huang,Songxue Wang,Yiyan Wang,Xianwu Chen,Zhenkun Lin,Ren-shan Ge
DOI: https://doi.org/10.1016/j.chemosphere.2019.05.122
IF: 8.8
2019-01-01
Chemosphere
Abstract:Tebuconazole is a triazole compound used agriculturally to treat plant pathogenic fungi. However, whether pubertal exposure to tebuconazole affects Leydig cell development remains unknown. Here, we exposed male Sprague-Dawley rats at 35 days of age to 0, 25, 50, or 100 mg kg(-1) day(-1) tebuconazole for 21 days. Tebuconazole exposure increased serum testosterone level but lowered estradiol level at a dose of 100 mg kg(-1), without affecting serum luteinizing hormone and follicle-stimulating hormone concentrations. Tebuconazole up-regulated the expression of testicular Cyp11a1, Hsd11b1, and Fshr genes as well as their proteins at a dose of 100 mg kg(-1). However, tebuconazole did not stimulate the proliferation of Leydig cells. Tebuconazole in vitro inhibits aromatase activity in primary rat Leydig cells with IC50 value of 40 mu mol/L. In conclusion, tebuconazole exposure stimulates pubertal Leydig cell differentiation via inhibiting aromatase activity. (C) 2019 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?